Home » Newsletters » BioWorld

BioWorld

Aug. 24, 2001

View Archived Issues

U.S. Patent Disclosures

QLT Gets Additional Approval Of Visudyne In CNV Indication

Aradigm Raises $14.6M To Fuel Trials, Manufacturing Capability

Vancomycin, Last-Hope Antibiotic, Facing Imminent Drug Resistance, Resensitizes Recalcitrant Germs

Other News To Note